---
$id: https://graph.org.ai/products/commodity/51131816
$type: Product
source: UNSPSC
code: "51131816"
title: "Carbazochrome"
class: "51131800"
classTitle: "Coagulants and systemic hemostatic agents"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carbazochrome

**UNSPSC Code**: 51131816
**Class**: [Coagulants and systemic hemostatic agents](Coagulants and systemic hemostatic agents.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a hemostatic agent with the molecular formula C10H12N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 81F061RQS4, chemically known as 5,6-indolinedione, 3-hydroxy-1-methyl-, 5-semicarbazone but generally known as carbazochrome, which bears US NIH Compound Identifier 5360410. Carbazochrome most often comes in base, salicylate, and sodium sulfonate forms. European Medicines Agency schedules Carbazochrome in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13237MIG. The term CARBAZOCHROME is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). World Health Organization schedules carbazochrome in its Anatomical Therapeutic Chemical (ATC) Classification. CARBAZOCHROME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carbazochrome under HS 29339990 and SITC 51577. As of Q4 2014, CARBAZOCHROME remains the US FDA Preferred Term for this commodity. Carbazochrome bears US NLM identifiers UMLS ID C0006972 and NCI Concept Code C79939. SMILES: CN1CC(C2=C/C(=N/NC(=O)N)/C(=O)C=C21)O.

